EXTRADIGESTIVE MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE: DEMOGRAPHIC, CLINICAL, BIOLOGICAL AND ENDOSCOPIC FEATURES

Authors

  • Oana-Bogdana BARBOI University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi
  • Cristina CIJEVSCHI-PRELIPCEAN University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi
  • Catalina MIHAI University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi
  • Mariana FLORIA University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi
  • I. CHIRILA Institute of Public Health
  • Ana-Maria DARIE University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi
  • V.L. DRUG University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi
  • G. BALAN University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

Abstract

Gastroesophageal reflux disease (GERD) with extradigestive manifestations is a disorder increasingly recognized both by gastroenterologists, pneumologists, otolaryngologists and cardiologists. Aim: To evaluate the demographical, clinical, biological and endoscopic features of the patients with gastroesophageal reflux disease and extradigestive manifestations (chronic laryngitis, asthma, pseudoangina). Material and methods: Prospective case-control study, including 137 patients selected from patients referred to the Iasi Institute of Gastroenterology and Hepatology between July 2014 - September 2015. In the presence of typical GERD symptoms (heartburn or regurgitation), the patients were assessed by upper digestive endoscopy for the detection or exclusion of esophagitis. Despite the absence of esophageal lesions, the patients were further assessed by impedance-pHmetry. Results: Depending on the dominant extradigestive manifestation, the patients were assigned into 3 groups: 94 chronic laryngitis patients, 24 asthma patients and 19 pseudoangina patients. Females were more frequent among pseudoangina patients (68.4%). Mean age of the male patients with dysphonia or asthma was lower (p=0.002), the majority (78.1%) living in urban areas. Obesity was predominant in pseudoangina group (52.6%), as compared to dysphonia group (16%) the differences being statistically significant (p=0.002). A share of 57.9% of pseudoangina patients were dyslipidemic, in contrast to dysphonia (24.5%) or asthma group (37.5%) (p=0.013). Esophagitis was also more frequent at pseudoangina group (84.2%), but with no significant statistical difference between the study groups (79.8% and 75%, respectively) (p=0.115). It seems that Helicobacter pylori infection tends to be protective in patients with GERD and pseudoangina (RR=0.61), but it can not be extrapolated to the general population (p=0.459).

Author Biographies

  • Oana-Bogdana BARBOI, University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

    Faculty of Medicine
    Department of Medical Specialties (I)

  • Cristina CIJEVSCHI-PRELIPCEAN, University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

    Faculty of Medicine
    Department of Medical Specialties (I)

  • Catalina MIHAI, University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

    Faculty of Medicine
    Department of Medical Specialties (I)

  • Mariana FLORIA, University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

    Faculty of Medicine
    Department of Medical Specialties (I)

  • Ana-Maria DARIE, University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

    Faculty of Medicine
    Department of Medical Specialties (I)

  • V.L. DRUG, University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

    Faculty of Medicine
    Department of Medical Specialties (I)

  • G. BALAN, University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi

    Faculty of Medicine
    Department of Medical Specialties (I)

References

1. Nilsson M, Johnsen R, Ye W et al. Prevalence of gastro-oesophageal reflux symptoms and the influ-ence of age and sex. Scand J Gastroenterol 2004; 39: 1040-1045.
2. Cobzeanu MD, Voineag M, Drug VL, Ciubotaru A, Cobzeanu BM, Palade OD. Laryngeal morpho-logical changes due to gastroesophageal reflux disease. Rev Med Chir 2012; 116(4): 1011-1015.
3. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterol 2004; 126: 660–664.
4. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995; 27: 67–70.
5. Garcia Rodriguez LA, Ruigomez A. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest 2008; 134 (6): 1223-1230.
6. Beedassy A, Kats PO, Gruber A. Prior sensitization of gastroesophageal mucosa by acid reflux pre-disposis to reflux induced chest pain. J Clin Gastroenterol 2000; 31(2): 121-124.
7. Festi D, Scaioli E, Baldi F et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol 2009; 15: 1690–1701.
8. Yuksel ES, Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux disease: cough, asthma, laryngitis, chest pain. Swiss Med Wkly 2012; 142: 13544.
9. Voineag M, Drug VL, Indrei MD, Cobzeanu MD. Algoritm de diagnostic şitratamentînfaringolaringita de reflux (Diagnostic and treatment algorithm for pharingolaryngeal reflux). Rev Med Chir 2011; 105 (2): 405-411.
10. Dickman R, Mattek N, Holub J, Peters D, Fass R. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol 2007; 102 (6): 1173–1179.
11. Koufman JA, Belafsky PC et al. Prevalence of esophagitis in patients with pH-documented laryn-gopharyngeal reflux. Laryngoscope 2002; 112: 1606-1609.
12. Noble K.A. Gastroesophageal reflux disease. J Perianesth Nurs 2013; 28 (2): 102-106.
13. Koike T, Ohara S, Sekine H. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001; 1: 330–334.
14. Loffeld FJLF, Werdmuller BFM, Kuster JA. Colonization with cagA positive Helicobacter pylori prevastrains inversely associated with reflux esophagitis and Barrett’s esophagus. Digestion 2000; 62: 95–99.
15. Fallone CA, Barkun AW, Friedman G. Is Helicobacter pylori eradication associated with gas-troesophageal reflux disease? Am J Gastroenterol 2000; 95: 914–920.
16. Rubenstein J., Inadomi J., Scheiman J. et al. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 2014; 12 (2): 239-245.
17. Wu JC, Chan FK, Wang SK. Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux esophagitis. Aliment Pharmacol Ther 2002; 16: 545–552.

Additional Files

Published

2016-06-30

Issue

Section

INTERNAL MEDICINE - PEDIATRICS